Dr. Lena Thin
Claim this profileFiona Stanley Hospital
Studies Crohn's Disease
Studies Colitis
6 reported clinical trials
6 drugs studied
Clinical Trials Lena Thin is currently running
TAK-279
for Ulcerative Colitis
The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The participants will take capsules of either TAK-279 or placebo for up to 3 months (12 weeks). Then all the participants will receive TAK-279 for the rest of the treatment part of the study (1 year or 52 weeks). During the study, participants will visit their study clinic several times.
Recruiting0 awards Phase 21 criteria
Vedolizumab
for Crohn's Disease
Transmural healing (TMH) is recognized as a potentially important measure of Crohn's disease (CD) activity but not a formal target. Observational studies suggest that TMH may be associated with better long-term outcomes. The study will evaluate TMH using noninvasive intestinal ultrasound (IUS), a patient-friendly technique that can be performed routinely in clinical practice. The aim of the study is to determine if treating to a target of corticosteroid-free (CS-free) IUS outcomes + clinical symptoms + biomarkers is superior to a target of clinical symptoms + biomarkers alone in achieving CS-free endoscopic remission measured by the Simple Endoscopic Score for Crohn's Disease (SES-CD). Qualified participants will be randomly assigned in a 1:1 ratio to one of 2 different target treatment groups. Group 1: Participants will be treated over 48 weeks to achieve a target of corticosteroid-free IUS-based outcomes + clinical remission + biomarker remission. At Week 22 and 30, the IUS-based component of the target will be IUS response and at Week 38, the final treatment target will be TMH. Group 2: Participants will be treated over 48 weeks to achieve a target of corticosteroid-free clinical remission + biomarker remission.
Recruiting3 awards Phase 43 criteria
More about Lena Thin
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Lena Thin has experience with
- Mirikizumab
- No Treatment
- Vedolizumab
- TAK-279
- BMS-986165
- Placebo
Breakdown of trials Lena Thin has run
Crohn's Disease
Ulcerative Colitis
Crohn's disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lena Thin specialize in?
Lena Thin focuses on Crohn's Disease and Colitis. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Lena Thin currently recruiting for clinical trials?
Yes, Lena Thin is currently recruiting for 2 clinical trials in Murdoch Western Australia. If you're interested in participating, you should apply.
Are there any treatments that Lena Thin has studied deeply?
Yes, Lena Thin has studied treatments such as Mirikizumab, No treatment, Vedolizumab.
What is the best way to schedule an appointment with Lena Thin?
Apply for one of the trials that Lena Thin is conducting.
What is the office address of Lena Thin?
The office of Lena Thin is located at: Fiona Stanley Hospital, Murdoch, Western Australia 6150 Australia. This is the address for their practice at the Fiona Stanley Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.